- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01570400
Treatment of Social Phobia With Combined Cognitive Bias Modification and iCBT (SOFIE13a)
Reduction of Social Phobia Symptoms With Combined Internet-Based Cognitive Bias Modification and Cognitive Behavioral Therapy
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Västerbotten
-
Umeå, Västerbotten, Sweden, 90187
- Department of Psychology, Umeå University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Written informed consent provided
- Diagnosed social phobia (according to DSM-IV criteria)
- Access to computer with internet connection
Exclusion Criteria:
- Severe depression (and/or suicidal behavior)
- Suffer from other severe psychiatric condition (e.g. psychosis)
- Non-stable use of medication (3 months stable dosage)
- Undergoing other, parallel psychological treatment
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: CBM training program variant 1 + iCBT
Cognitive bias modification training program variant 1 combined with iCBT
|
Established form of internet-administered cognitive behavioral therapy.
Controlled progress, self-help modules with psychoeducative texts, assignments and homework.
Therapist assisted.
Computerized, internet-based training program for implicit modification of cognitive bias of attention, variant 4. Participant is exposed to a pair of words or a pair of faces -- either neutral-negative, neutral-positive, or negative-positive -- for 500ms-1000ms, followed by a probe (< or >) in the previous position of ONE of these words or faces and is then asked to press the corresponding arrow button on a keyboard. A total of 96 word pairs and 96 face pairs are shown during a session. One third is neutral-negative, one third is neutral-positive, and one third is negative-positive. The probe always follows the more negative word or face. Duration: approx. 10 min. per session. Frequency: Once every day for 2 weeks. |
EXPERIMENTAL: CBM training program variant 2 + iCBT
Cognitive bias modification training program variant 2 combined with iCBT
|
Established form of internet-administered cognitive behavioral therapy.
Controlled progress, self-help modules with psychoeducative texts, assignments and homework.
Therapist assisted.
Computerized, internet-based control training program, variant 2. Participant is exposed to a pair of words or a pair of faces -- either neutral-negative, neutral-positive, or negative-positive -- for 500ms-1000ms, followed by a probe (< or >) in the previous position of ONE of these words or faces and is then asked to press the corresponding arrow button on a keyboard. A total of 96 word pairs and 96 face pairs are shown during a session. One third is neutral-negative, one third is neutral-positive, and one third is negative-positive. The probe follows the more positive stimulus and the more negative stimulus with equal frequency. Duration: approx. 10 min. per session. Frequency: Once every day for 2 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR)
Time Frame: 24 hours
|
The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear.
It is commonly used to study outcomes in clinical trials.
The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations.
It is not intended for use as a self-reporting diagnosis.
|
24 hours
|
Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR)
Time Frame: 11 weeks
|
The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear.
It is commonly used to study outcomes in clinical trials.
The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations.
It is not intended for use as a self-reporting diagnosis.
|
11 weeks
|
Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR)
Time Frame: 4 months
|
The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear.
It is commonly used to study outcomes in clinical trials.
The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations.
It is not intended for use as a self-reporting diagnosis.
|
4 months
|
Change from baseline in Liebowitz Social Anxiety Scale Self-Rated (LSAS-SR)
Time Frame: Two weeks into treatment
|
The Liebowitz Social Anxiety Scale (LSAS) is a questionnaire by psychiatrist and researcher, Michael Liebowitz, whose objective is to assess the range of social interaction and performance situations which patients with social anxiety disorder may fear.
It is commonly used to study outcomes in clinical trials.
The scale features 24 items, 13 relating to performance anxiety and 11 concerning social situations.
It is not intended for use as a self-reporting diagnosis.
|
Two weeks into treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 24 hours
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
24 hours
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 24 hours
|
9-item depression rating scale.
|
24 hours
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 11 weeks
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
11 weeks
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 4 months
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
4 months
|
Change from baseline in Quality Of Life Inventory (QOLI)
Time Frame: 2 weeks into treatment
|
The QOLI assessment yields an overall score and a profile of problems and strengths in 16 areas of life such as love, work and play.
The QOLI test is a measure of positive psychology and positive mental health.
|
2 weeks into treatment
|
Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale
Time Frame: 24 hours
|
Self-rated measurements of social anxiety/phobia.
|
24 hours
|
Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale
Time Frame: 11 weeks
|
Self-rated measurements of social anxiety/phobia.
|
11 weeks
|
Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale
Time Frame: 4 months
|
Self-rated measurements of social anxiety/phobia.
|
4 months
|
Change from baseline in Social Phobia Scale + Social Interaction Anxiety Scale
Time Frame: 2 weeks into treatment
|
Self-rated measurements of social anxiety/phobia.
|
2 weeks into treatment
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 11 weeks
|
9-item depression rating scale.
|
11 weeks
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 4 months
|
9-item depression rating scale.
|
4 months
|
Change from baseline in Montgomery-Åsberg Depression Rating Scale (MADRS)
Time Frame: 2 weeks into treatment
|
9-item depression rating scale.
|
2 weeks into treatment
|
Change from baseline in mini-SPIN
Time Frame: Daily, 1-15 days into treatment
|
Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale.
|
Daily, 1-15 days into treatment
|
Change from baseline in mini-SPIN
Time Frame: 11 weeks
|
Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale.
|
11 weeks
|
Change from baseline in mini-SPIN
Time Frame: 4 months
|
Mini-SPIN is a three-item self-rating scale for assessment of symptoms of social phobia using a five-point Likert scale.
|
4 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Boettcher J, Andersson G, Carlbring P; SOFIE-13 Research Group. Combining attention training with cognitive-behavior therapy in Internet-based self-help for social anxiety: study protocol for a randomized controlled trial. Trials. 2013 Mar 8;14:68. doi: 10.1186/1745-6215-14-68.
- Boettcher J, Hasselrot J, Sund E, Andersson G, Carlbring P. Combining attention training with internet-based cognitive-behavioural self-help for social anxiety: a randomised controlled trial. Cogn Behav Ther. 2014;43(1):34-48. doi: 10.1080/16506073.2013.809141. Epub 2013 Jul 30.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SOFIE13a
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Social Phobia
-
San Diego State UniversityNational Institute of Mental Health (NIMH)CompletedSocial Anxiety Disorder | Social PhobiaUnited States
-
Umeå UniversityUppsala UniversityCompleted
-
Umeå UniversityCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH)CompletedSocial PhobiaUnited States
-
University of MinnesotaAstraZenecaCompletedSocial PhobiaUnited States
-
Modum BadCompleted
-
VU University of AmsterdamCompletedSocial Anxiety Disorder | Social PhobiaNetherlands
-
McMaster UniversityHamilton Health Sciences Corporation; Janssen-Ortho Inc., CanadaTerminated
-
Pherin Pharmaceuticals, Inc.CompletedSocial Anxiety Disorder | Social PhobiaUnited States
Clinical Trials on Internet-administered cognitive behavioral therapy (iCBT)
-
Linkoeping UniversityCompletedDepressive Symptoms | Depressive Disorder, MajorSweden
-
Karolinska InstitutetDeakin UniversityRecruiting
-
Linkoeping UniversityRecruitingAnxiety Symptoms | Depression SymptomsSweden
-
Karolinska InstitutetVastra Gotaland Region; Region StockholmActive, not recruiting
-
Karolinska InstitutetRegion StockholmCompleted
-
Umeå UniversityCompleted
-
Region of Southern DenmarkUniversity of AarhusRecruitingAnxiety DisordersDenmark
-
Region SkaneLund UniversityActive, not recruiting
-
University of AarhusUniversity of Southern DenmarkCompletedAnxiety DisordersDenmark
-
Karolinska InstitutetCompletedObsessive-compulsive DisorderSweden